Reference : Pharma clinics. Comment je traite.... Certaines maladies metaboliques grace a une interv...

	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Pharmacy, pharmacology & toxicology
	To cite this reference:	http://hdl.handle.net/2268/12878

Title :	Pharma clinics. Comment je traite.... Certaines maladies metaboliques grace a une intervention pharmacologique ciblee sur l'intestin.
Language :	French
Alternative title :	[fr] Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine
Author, co-author :	Scheen, André [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Publication date :	1998
Journal title :	Revue Médicale de Liège
Publisher :	Hopital de Baviere
Volume :	53
Issue/season :	11
Pages :	646-50
ISSN :	0370-629X
City :	Liège
Country :	Belgique
Keywords :	[en] Acarbose ; Anion Exchange Resins/adverse effects/therapeutic use ; Anti-Obesity Agents/adverse effects/therapeutic use ; Antilipemic Agents/adverse effects/therapeutic use ; Cholestyramine/adverse effects/therapeutic use ; Diabetes Mellitus/drug therapy ; Enzyme Inhibitors/adverse effects/therapeutic use ; Humans ; Hypercholesterolemia/drug therapy ; Hypoglycemia/drug therapy ; Hypoglycemic Agents/adverse effects/therapeutic use ; Intestine, Small/drug effects ; Lactones/adverse effects/therapeutic use ; Lipase/antagonists & inhibitors ; Metabolic Diseases/diet therapy/drug therapy ; Trisaccharides/adverse effects/therapeutic use ; alpha-Glucosidases/antagonists & inhibitors
Abstract :	[en] Besides the classical dietary regimen, it is possible to use specific pharmacological approaches, targeted at the intestine, in order to treat some metabolic disorders. Three approaches will be described: anionic resins for treating hypercholesterolaemia, alpha-glucosidase inhibitors for treating diabetes mellitus and reactive hypoglycaemia, and intestinal lipase inhibitors for treating obesity. All these drugs are based on original concepts, but their clinical use is often limited by the occurrence of digestive side-effects. The latter may generally be reduced by progressive and individual titration of the dosage of each drug and/or by following an appropriate diet.
Permalink :	http://hdl.handle.net/2268/12878

There is no file associated with this reference.

All documents in ORBi are protected by a user license.

 

© ULg Library Network |  Feedback |  ORBi legal notices

Dspace v1.5